The Daily Express has published that scientists are working on the development of a drug, which may prevent breast cancer in a fifth of patients.

The study published in the British Journal of Cancer has said that Scientists are studying the role of a gene known as C35 in breast cancer cells. The main reason behind their interest in these cells is because C35 protein is produced by 40 to 50% breast tumours.

Scientists in their laboratory tests discovered that the cells, which produce C35 protein in excess, show the same qualities as that of cancer cells. This would help the doctors to invent a new drug to stop the breast cancer development.

The researchers from the University of Edinburg, in their lab, looked for some chemicals which could prevent C35. however, more and deep research is required to finally reach for such a chemical, as it should be harmless for humans.

The study is based on tissue samples taken from 122 breast cancers, which were in their initial stages. They also took some normal breast tissues into consideration. Then they made a comparison between the produced C35 protein.

The Scottish Funding Council and Breakthrough Breast Cancer had provided the funds for this study. Two main authors of the story are associated with Vaccinex Inc., a drug making Company.